INS and Alzheimer disease: Taken together, these findings suggest that AD pathological processes may be triggered or exacerbated by peripheral insulin resistance and that Aβ may itself induce brain insulin resistance and synapse loss, raising the possibility that insulin treatment may correct these pathological events.